{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:59:19Z","timestamp":1770494359990,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.htct.2024.05.007","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T01:38:00Z","timestamp":1722649080000},"page":"103668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0932-5800","authenticated-orcid":false,"given":"Daniel Mazza","family":"Matos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.htct.2024.05.007_bib0001","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.htct.2021.08.012","article-title":"A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry","volume":"45","author":"Ozdemir","year":"2023","journal-title":"Hematol Transfus Cell Ther"},{"issue":"4","key":"10.1016\/j.htct.2024.05.007_bib0002","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ajcp\/108.4.378","article-title":"Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b)","volume":"108","author":"Moreau","year":"1997","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.htct.2024.05.007_bib0003","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/hon.2510","article-title":"CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia","volume":"36","author":"D'Arena","year":"2018","journal-title":"Hematol Oncol"},{"issue":"4","key":"10.1016\/j.htct.2024.05.007_bib0004","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/ijlh.13567","article-title":"Concordance between flow cytometry CLL scores","volume":"43","author":"Sorigue","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"10.1016\/j.htct.2024.05.007_bib0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/bjh.14901","article-title":"Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200","volume":"179","author":"K\u00f6hnke","year":"2017","journal-title":"Br J Haematol"},{"issue":"13","key":"10.1016\/j.htct.2024.05.007_bib0006","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1002\/cam4.3983","article-title":"A new score including CD43 and CD180: increased diagnostic value for atypical chronic lymphocytic leukemia","volume":"10","author":"Li","year":"2021","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.htct.2024.05.007_bib0007","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10408363.2022.2114418","article-title":"Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders","volume":"60","author":"G\u00fcell","year":"2023","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"10.1016\/j.htct.2024.05.007_bib0008","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cyto.b.21595","article-title":"Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: an European research initiative on CLL (ERIC) & European society for clinical cell analysis (ESCCA) harmonisation project","volume":"94","author":"Rawstron","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"issue":"5","key":"10.1016\/j.htct.2024.05.007_bib0009","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/cyto.b.21760","article-title":"Refining the limits of borderline lymphoproliferative disorders","volume":"96","author":"Sorigue","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"10.1016\/j.htct.2024.05.007_bib0010","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1111\/ijlh.13791","article-title":"Overlap between CD23 and CD200 in leukemic lymphoproliferative disorders","volume":"44","author":"G\u00fcell","year":"2022","journal-title":"Int J Lab Hematol"},{"issue":"5","key":"10.1016\/j.htct.2024.05.007_bib0011","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cyto.b.21890","article-title":"FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study","volume":"98","author":"Sorigue","year":"2020","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"10.1016\/j.htct.2024.05.007_bib0012","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/cyto.b.22151","article-title":"CD5-negative chronic lymphocytic leukemia: does this entity really exist?","volume":"106","author":"Matos","year":"2024","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.htct.2024.05.007_bib0013","series-title":"Smudge Cells in Peripheral Blood Smears Did Not Differentiate Chronic Lymphocytic Leukemia from Other B-cell Chronic Lymphoprolipherative Diseases","first-page":"333","author":"Matos","year":"2009"},{"issue":"1","key":"10.1016\/j.htct.2024.05.007_bib0014","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hon.2461","article-title":"Spectrum and immunophenotyping of 653 patients with B-cell chronic lymphoproliferative disorders in China: a single-centre analysis","volume":"36","author":"Miao","year":"2018","journal-title":"Hematol Oncol"},{"issue":"7","key":"10.1016\/j.htct.2024.05.007_bib0015","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4065\/83.7.776","article-title":"Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients","volume":"83","author":"Morice","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.htct.2024.05.007_bib0016","first-page":"586","article-title":"Improving the differential diagnosis of CD5+ B-lymphoproliferative disorders","author":"Rawstron","year":"2016","journal-title":"EHA Meet;"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137924002773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137924002773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T13:02:21Z","timestamp":1741870941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137924002773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2531137924002773"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2024.05.007","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2024.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"103668"}}